QURE vs TLRY · rev $16.1M vs rev $915.5M
Uniqure NV (QURE) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Uniqure NV (QURE) is a biotechnology company listed on NASDAQ.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
QURE currently screens at market cap $3.04B. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the QURE and TLRY stock pages for the full models.
Not investment advice.